Selected article for: "cytosolic dna and DNA cytosolic sensor"

Author: Ma, Ruihua; Ortiz Serrano, Tatiana P.; Davis, Jennifer; Prigge, Andrew D.; Ridge, Karen M.
Title: The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease
  • Cord-id: 5k7nlmqk
  • Document date: 2020_8_28
  • ID: 5k7nlmqk
    Snippet: The presence of DNA in the cytosol is usually a sign of microbial infections, which alerts the host innate immune system to mount a defense response. Cyclic GMP-AMP synthase (cGAS) is a critical cytosolic DNA sensor that elicits robust innate immune responses through the production of the second messenger, cyclic GMP-AMP (cGAMP), which binds and activates stimulator of interferon genes (STING). However, cGAS binds to DNA irrespective of DNA sequence, therefore, self-DNA leaked from the nucleus o
    Document: The presence of DNA in the cytosol is usually a sign of microbial infections, which alerts the host innate immune system to mount a defense response. Cyclic GMP-AMP synthase (cGAS) is a critical cytosolic DNA sensor that elicits robust innate immune responses through the production of the second messenger, cyclic GMP-AMP (cGAMP), which binds and activates stimulator of interferon genes (STING). However, cGAS binds to DNA irrespective of DNA sequence, therefore, self-DNA leaked from the nucleus or mitochondria can also serve as a cGAS ligand to activate this pathway and trigger extensive inflammatory responses. Dysregulation of the cGAS-STING pathway is responsible for a broad array of inflammatory and autoimmune diseases. Recently, evidence has shown that self-DNA release and cGAS-STING pathway over-activation can drive lung disease, making this pathway a promising therapeutic target for inflammatory lung disease. Here, we review recent advances on the cGAS-STING pathway governing self-DNA sensing, highlighting its role in pulmonary disease.

    Search related documents:
    Co phrase search for related documents
    • aberrant activation and acid inducible gene: 1, 2
    • aberrant activation and activation phosphorylation: 1
    • aberrant activation and activation recruitment: 1, 2, 3, 4, 5
    • aberrant activation and activator transducer: 1
    • aberrant activation and acute kidney injury: 1, 2
    • aberrant activation and acute lung injury: 1, 2, 3, 4
    • aberrant activation and acute respiratory distress syndrome: 1, 2
    • aberrant activation and adaptive immune system: 1
    • aberrant activation and lung cancer: 1, 2
    • aberrant activation and lung damage: 1, 2, 3
    • aberrant activation and lung disease: 1, 2, 3
    • aberrant activation and lung fibrosis: 1, 2, 3
    • aberrant activation and lung infection: 1, 2
    • aberrant activation and lung inflammation: 1
    • aberrant activation and lung inflammatory: 1
    • aberrant activation and lung inflammatory injury: 1
    • aberrant activation and lung injury: 1, 2, 3, 4, 5, 6, 7
    • aberrant activation and lung tissue: 1, 2, 3, 4
    • aberrant activation and lupus erythematosus: 1